Skip to main content

Table 1 Characteristics of 1007 study subjects

From: An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study

  n Mean Range n Mean Range P
Anti-platelet therapy Absent Present  
Age in years 499 62.1 22.2-89.5 508 67.6 36.0-92.6 < .001
Gender: male 499 39.7%   508 51.6%   < .001
Race: white, 497 96.6%   507 98.0%   .15
Body mass index in kg/m2 492 34.5 16.1-64.6 502 33.1 15.8-68.0 .003
Glycosylated hemoglobin A1C 497 7.1% 4.0-13.5 506 7.1% 4.9-12.9 .85
More than 1 comorbid condition 499 45.1%   508 53.5%   .007
Current smoker 498 18.5%   508 15.4%   .19
Number of medications 499 7.7 0-29 508 9.8 1-29 < .001
Self-reported history of malignancy 499 13.0%   508 12.2%   .70
History of cancer Absent Present  
Age in years 880 65.2 22.2-91.7 127 69.1 34.5-92.6 < .001
Gender: male 880 46.2%   127 41.7%   .34
Race: white, 878 97.3%   126 97.6%   .82
Body mass index in kg/m2 868 34.0 15.8-68.0 126 32.6 19.7-53.8 .05
Glycosylated hemoglobin A1C 876 7.1% 4.0-13.5 127 7.0% 4.8-13.3 .13
More than 1 comorbid condition 880 46.2%   127 71.7   < .001
Current smoker 879 17.8%   127 11.0%   .06
Number of medications 880 8.6 0-29 127 9.9 0-29 .003
Anti-platelet therapy 880 50.7%   127 48.8%   .70